对 (2R,6R; 2S,6S) -Hydroxynorketamine (HNK) 和其衍生物的抗抑郁活性进行研究
Dongdong Zang1, Xuemei Yang2, Hao Wang3
1Department of Neonatology, Shenzhen Children's Hospital, Shenzhen City, Guangdong Province, China.
Clinics (Sao Paulo, Brazil)
|July 12, 2024
概括
这项研究研究了 (2R,6R; 2S,6S) -HNK及其合成化合物的抗抑郁作用. 化合物C和D显示出潜在的抗抑郁作用,而HNK显示出快速但短暂的效果.
科学领域:
- 神经科学是一个神经科学.
- 药理学 药理学是指药理学的学科.
- 药用化学 医学化学
背景情况:
- 探索用于治疗抑郁症的新型化合物至关重要.
- 了解抗抑郁药活性背后的神经生物学机制正在进行中.
- 合成和评估特定的化学实体,如HNK衍生物,有助于这个领域.
研究的目的:
- 研究 (2R,6R; 2S,6S) -HNK及其合成化合物的潜在抗抑郁作用.
- 使用已建立的行为模型来选合成的HNK化合物对抗抑郁药物的活性.
主要方法:
- 四种HNK化合物是从2- ((Chlorophenyl) Cyclopentylmethanone中合成的.
- 用小鼠的强迫游泳测试,发动机敏化测试和有条件的位置偏好测试来选抗抑郁药物的活性.
- 测量了行为变化,包括静止时间和运动运动活动.
主要成果:
- 在治疗后1小时和7天,HNK治疗 (10毫克) 显著减少了小鼠的不运动时间.
- 化合物C和D在强迫游泳测试中显示出显著的抗抑郁作用.
- 化合物C和D增加了运动运动活动,并诱导了有条件的位置偏好,这表明它具有抗抑郁作用.
结论:
- 根据行为测试,化合物C和D表现出潜在的抗抑郁作用.
- 虽然HNK表现出抗抑郁药效应的迅速发作,但其持续时间似乎有限.
- 需要进一步的研究来阐明这些化合物的机制和治疗潜力.
更多相关视频
10:20Method for Identifying Small Molecule Inhibitors of the Protein-protein Interaction Between HCN1 and TRIP8b
Published on: November 11, 2016
8.5K
07:58Behavioral and Network Pharmacology-Based Analyses for the Traditional Mongolian Medicine Zadi-5 in a Rat Model of Depression
Published on: February 24, 2023
498
相关概念视频
01:17Sedatives and Hypnotics Drugs: Miscellaneous Agents
166
Sedatives and hypnotics encompass a wide range of substances, each with its unique mechanism of action, uses, and potential adverse effects.
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
166
01:23Antidepressant Drugs: MAOIs and Other Agents
215
Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...
215
01:16Adrenergic Agonists: Chemistry and Structure-Activity Relationship
2.8K
Adrenergic agonists' structure-activity relationship (SAR) determines their selectivity and efficacy. These agonists comprise a phenylethylamine moiety with an aromatic ring and an ethylamine side chain.
Aromatic ring substitutions: Substituting the aromatic ring with –OH groups at positions 3 and 4 yields catecholamines (e.g., epinephrine), which have a high affinity for adrenoceptors. Hydrogen bonding between –OH groups and receptors enhances adrenergic activity.
Separation of...
Aromatic ring substitutions: Substituting the aromatic ring with –OH groups at positions 3 and 4 yields catecholamines (e.g., epinephrine), which have a high affinity for adrenoceptors. Hydrogen bonding between –OH groups and receptors enhances adrenergic activity.
Separation of...
2.8K
01:28Drug-Receptor Interaction: Antagonist
2.9K
An antagonist is a drug that binds strongly to a receptor without activating it. An antagonist prevents other molecules, such as neurotransmitters or hormones, from binding to the receptor and triggering a cellular response. Such interaction effectively hinders the normal physiological processes mediated by the receptor, resulting in various pharmacological effects depending on the specific receptor targeted.
Antagonists can be classified as competitive or noncompetitive based on their...
Antagonists can be classified as competitive or noncompetitive based on their...
2.9K
01:28Chemotherapy-Induced Nausea and Vomiting: Neurokinin-1 Receptor Antagonists
158
Neurokinin 1 (NK1) receptors are distributed across the GI tract, vagal afferents, and key CNS regions including the central vomiting center and chemoreceptor trigger zone (CTZ) Chemotherapy agents stimulate enterochromaffin cells in the gastrointestinal (GI) tract to release large amounts of substance P (SP). SP is a neuropeptide released by specific sensory nerves in response to many different stressors, including those in the GI mucosa affected by chemotherapy. SP binds and activates...
158
01:21Drugs Affecting Neurotransmitter Release or Uptake
1.0K
Certain drugs can affect how neurotransmitters called catecholamines, are released or taken back up in the adrenergic neuron. They can have different effects on the body's sympathetic transmission. Reserpine, a natural compound found in the Rauwolfia shrub, blocks a transporter called vesicular monoamine transporter (VMAT), which leads to a buildup of catecholamines in the cell and reduces sympathetic transmission. Another drug called guanethidine works in multiple ways, including blocking...
1.0K